WHO approves China’s Sinovac COVID-19 jab

The World Health Organization on Tuesday approved the Sinovac COVID-19 vaccine for emergency use—the second Chinese jab to receive the WHO’s green light.

The United Nations health agency signed off on the Beijing-based firm Sinovac’s two-dose vaccine CoronaVac, which is already being deployed in several countries around the world.

The chief of the WHO said, “The easy storage requirements of CoronaVac make it very suitable for low-resource settings. It’s now crucial to get these life-saving tools to the people that need them quickly.”

The WHO said the emergency use listing gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards.

Last month, Sinopharm became the first Chinese vaccine to be approved by the WHO. It has also given EUL status to vaccines made by Pfizer, Moderna, Johnson & Johnson, and the AstraZeneca jab produced in India, South Korea and the EU.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.